PubMed

APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes: results of a prospective observational follow-up study.

Araki S, Koya D, Makiishi T, Sugimoto T, Isono M, Kikkawa R, Kashiwagi A, Haneda M.

Diabetes Care. 2003 Aug;26(8):2416-20.PMID: 12882872 [PubMed - indexed for MEDLINE]Related articlesFree article

The relationship of the apolipoprotein E gene polymorphism Turkish Type 2 diabetic patients with and without nephropathy.

Erdogan M, Eroglu Z, Biray C, Karadeniz M, Cetinkalp S, Kosova B, Gunduz C, Topcuoglu N, Ozgen G, Yilmaz C.

J Endocrinol Invest. 2009 Mar;32(3):219-22.PMID: 19542737 [PubMed - indexed for MEDLINE]Related articles

Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population.

Kokubo Y, Chowdhury AH, Date C, Yokoyama T, Sobue H, Tanaka H.

Stroke. 2000 Jun;31(6):1299-306. Erratum in: Stroke 2000 Sep;31(9):2279. PMID: 10835448 [PubMed - indexed for MEDLINE]Related articlesFree article

The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.

Vaisi-Raygani A, Rahimi Z, Nomani H, Tavilani H, Pourmotabbed T.

Clin Biochem. 2007 Oct;40(15):1150-6. Epub 2007 Jul 6.PMID: 17689519 [PubMed - indexed for MEDLINE]Related articles

Co-inheritance of specific genotypes of HSPG and ApoE gene increases risk of type 2 diabetic nephropathy.

Liu L, Xiang K, Zheng T, Zhang R, Li M, Li J.

Mol Cell Biochem. 2003 Dec;254(1-2):353-8.PMID: 14674716 [PubMed - indexed for MEDLINE]Related articles

Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients.

Eto M, Saito M, Okada M, Kume Y, Kawasaki F, Matsuda M, Yoneda M, Matsuki M, Takigami S, Kaku K.

Am J Kidney Dis. 2002 Aug;40(2):243-51.PMID: 12148096 [PubMed - indexed for MEDLINE]Related articles

Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM.

Kimura H, Suzuki Y, Gejyo F, Karasawa R, Miyazaki R, Suzuki S, Arakawa M.

Am J Kidney Dis. 1998 Apr;31(4):666-73.PMID: 9531184 [PubMed - indexed for MEDLINE]Related articles

Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan.

Hsieh MC, Lin SR, Yang YC, Chen HC, Lin JN, Shin SJ.

J Nephrol. 2002 Jul-Aug;15(4):368-73.PMID: 12243365 [PubMed - indexed for MEDLINE]Related articles

Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study.

Hadjadj S, Belloum R, Bouhanick B, Gallois Y, Guilloteau G, Chatellier G, Alhenc-Gelas F, Marre M.

J Am Soc Nephrol. 2001 Mar;12(3):541-9.PMID: 11181802 [PubMed - indexed for MEDLINE]Related articlesFree article

Association between apolipoprotein E genetic polymorphism and the development of diabetic nephropathy in type 2 diabetic patients.

Kwon MK, Rhee SY, Chon S, Oh S, Woo JT, Kim SW, Kim JW, Kim YS, Jeong KH, Lee SH, Lee TW, Ihm CG.

Diabetes Res Clin Pract. 2007 Sep;77 Suppl 1:S228-32. Epub 2007 Jul 12.PMID: 17624465 [PubMed - indexed for MEDLINE]Related articles

Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation.

Guan J, Zhao HL, Baum L, Sui Y, He L, Wong H, Lai FM, Tong PC, Chan JC.

Nephrol Dial Transplant. 2009 Jun;24(6):1889-95. Epub 2009 Feb 14.PMID: 19218599 [PubMed - indexed for MEDLINE]Related articles

Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy.

Tarnow L, Stehouwer CD, Emeis JJ, Poirier O, Cambien F, Hansen BV, Parving HH.

Nephrol Dial Transplant. 2000 May;15(5):625-30.PMID: 10809802 [PubMed - indexed for MEDLINE]Related articlesFree article

Apolipoprotein E and progression of chronic kidney disease.

Hsu CC, Kao WH, Coresh J, Pankow JS, Marsh-Manzi J, Boerwinkle E, Bray MS.

JAMA. 2005 Jun 15;293(23):2892-9.PMID: 15956634 [PubMed - indexed for MEDLINE]Related articlesFree article

Influence of apolipoprotein E genotype on progression of diabetic nephropathy.

Joss N, Jardine A, Gaffney D, Boulton-Jones JM.

Nephron Exp Nephrol. 2005;101(4):e127-33. Epub 2005 Aug 19.PMID: 16113584 [PubMed - indexed for MEDLINE]Related articles

Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study.

Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Pagano G, Cavallo Perin P; Casale Monferrato Study.

Diabetes Care. 2003 Jul;26(7):2150-5.PMID: 12832328 [PubMed - indexed for MEDLINE]Related articlesFree article

APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies.

Araki S, Moczulski DK, Hanna L, Scott LJ, Warram JH, Krolewski AS.

Diabetes. 2000 Dec;49(12):2190-5.PMID: 11118024 [PubMed - indexed for MEDLINE]Related articlesFree article

Polymorphisms of the protein kinase C-beta gene (PRKCB1) accelerate kidney disease in type 2 diabetes without overt proteinuria.

Araki S, Haneda M, Sugimoto T, Isono M, Isshiki K, Kashiwagi A, Koya D.

Diabetes Care. 2006 Apr;29(4):864-8.PMID: 16567829 [PubMed - indexed for MEDLINE]Related articlesFree article

Apo E gene polymorphism on development of diabetic nephropathy.

Ilhan N, Kahraman N, Seçkin D, Ilhan N, Colak R.

Cell Biochem Funct. 2007 Sep-Oct;25(5):527-32.PMID: 16933203 [PubMed - indexed for MEDLINE]Related articles

Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age.

Heijmans BT, Slagboom PE, Gussekloo J, Droog S, Lagaay AM, Kluft C, Knook DL, Westendorp RG.

Am J Med Genet. 2002 Jan 22;107(3):201-8.PMID: 11807900 [PubMed - indexed for MEDLINE]Related articles

[Polymorphic gene markers of lipid metabolism are associated with diabetic nephropathy in patients with type 1 diabetes mellitus]

Iakunina NIu, Shestakova MV, Voron'ko OE, Vikulova OK, Sevost'ianov KV, Chugunova LA, Shamkhalova MSh, Dedov II, Nosikov VV.

Genetika. 2005 Jul;41(7):931-7. Russian. PMID: 16152798 [PubMed - indexed for MEDLINE]Related articles